Published in Ann Neurol on November 01, 1998
Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (2005) 1.52
Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. Glycobiology (2009) 1.19
Guillain Barré syndrome. Mol Pathol (2001) 1.17
Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes. J Neurol (2011) 1.12
Guillain-Barré syndrome and variants. Neurol Clin (2013) 1.06
Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol (2014) 0.92
Clinical applications of intravenous immunoglobulins in neurology. Clin Exp Immunol (2009) 0.92
Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome. PLoS One (2013) 0.91
Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey. Proc Jpn Acad Ser B Phys Biol Sci (2012) 0.90
Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand? J Neurol (2009) 0.90
Central motor conduction in patients with anti-ganglioside antibody associated neuropathy syndromes and hyperreflexia. J Neurol Neurosurg Psychiatry (2002) 0.89
Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Mediators Inflamm (2014) 0.87
Guillain-Barré syndrome complicating pregnancy and correlation with maternal and fetal outcome in North Eastern India: A retrospective study. Ann Indian Acad Neurol (2015) 0.86
Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair. J Neurosci (2010) 0.85
Guillain-Barré syndrome: natural history and prognostic factors: a retrospective review of 106 cases. BMC Neurol (2013) 0.84
Neurophysiological testing correlates with clinical examination according to fibre type involvement and severity in sensory neuropathy. J Neurol Neurosurg Psychiatry (2004) 0.83
Guillain-Barré Syndrome in India: population-based validation of the Brighton criteria. Vaccine (2011) 0.82
Acute motor axonal neuropathy associated with anal carcinoma: Paraneoplastic neurological syndrome or coincidence? Rep Pract Oncol Radiother (2011) 0.82
Prevalence of fatigue in Guillain-Barre syndrome in neurological rehabilitation setting. Ann Indian Acad Neurol (2014) 0.81
The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review. JAMA Neurol (2015) 0.81
Severe Guillain-Barré syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based review. Clin Rheumatol (2013) 0.81
Acute lung failure. Semin Respir Crit Care Med (2011) 0.81
Sural sparing pattern discriminates Guillain-Barré syndrome from its mimics. Muscle Nerve (2014) 0.81
Guillain-Barré syndrome in children. Neurol Sci (2010) 0.80
The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids. Mol Cell Proteomics (2016) 0.80
Guillain-barré syndrome combined with acute cervical myelopathy. J Korean Neurosurg Soc (2010) 0.80
Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin. Nat Rev Neurol (2015) 0.79
Distinct Clinical Characteristics of Pediatric Guillain-Barré Syndrome: A Comparative Study between Children and Adults in Northeast China. PLoS One (2016) 0.79
Therapy of immune neuropathies with intravenous immunoglobulins. J Neurol (2006) 0.79
More severe manifestations and poorer short-term prognosis of ganglioside-associated Guillain-Barré syndrome in Northeast China. PLoS One (2014) 0.79
Further insight on A-wave in acute and chronic demyelinating neuropathies. Neurol Sci (2010) 0.79
Clinical and electrophysiological features of post-traumatic Guillain-Barré syndrome. BMC Neurol (2017) 0.78
Lymphocyte transformation test detects a response to Campylobacter jejuni antigens in patients with Guillain-Barré syndrome. Med Microbiol Immunol (2010) 0.78
Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome. J Neurol (2008) 0.78
Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes. Neurology (2014) 0.78
Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barré syndrome. J Clin Immunol (2013) 0.78
Outcome of Guillain-Barre syndrome patients with respiratory paralysis. QJM (2015) 0.78
Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis. Fluids Barriers CNS (2011) 0.77
Relevance of anxiety in clinical practice of Guillain-Barre syndrome: a cohort study. BMJ Open (2012) 0.77
Association of Anti-GT1a Antibodies with an Outbreak of Guillain-Barré Syndrome and Analysis of Ganglioside Mimicry in an Associated Campylobacter jejuni Strain. PLoS One (2015) 0.77
Reversible conduction failure in acute motor axonal neuropathy. Ann Indian Acad Neurol (2014) 0.75
Changes in the severity and subtype of Guillain-Barré syndrome admitted to a specialist Neuromedical ICU over a 25 year period. J Neurol (2017) 0.75
Guillain-barre syndrome following spinal fusion for thoracic vertebral fracture. J Korean Neurosurg Soc (2011) 0.75
Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria. J Neurol (2017) 0.75
Outcome of Guillain - Barré Syndrome in Children: A prospective cohort study in a tertiary hospital in Upper Egypt. Electron Physician (2016) 0.75
Acute motor axonal neuropathy in a child with atypical presentation: a case report. Medicine (Baltimore) (2015) 0.75
Effect of stem cell transplantation for B-cell malignancies on disease course of associated polyneuropathy. J Neurol (2012) 0.75
Intact thumb reflex in areflexic Guillain Barré syndrome: A novel phenomenon. Ann Indian Acad Neurol (2014) 0.75
Guillain-Barré syndrome: clinical profile and management. Ger Med Sci (2015) 0.75
The clinical characteristics and short-term prognosis in elderly patients with Guillain-Barré syndrome. Medicine (Baltimore) (2017) 0.75
The tibialis anterior response revisited. J Neurol (2014) 0.75
Acute motor axonal neuropathy in a patient with prolonged CD4 depletion due to HIV: a local variant of macrophage activation syndrome? Oxf Med Case Reports (2015) 0.75
Early Electrodiagnostic Features of Upper Extremity Sensory Nerves Can Differentiate Axonal Guillain-Barré Syndrome from Acute Inflammatory Demyelinating Polyneuropathy. J Clin Neurol (2016) 0.75
Factors predicting poor outcome in patients with fulminant Guillaine-Barré syndrome. Ann Indian Acad Neurol (2014) 0.75
Zika Virus Infection and Guillain-Barré Syndrome in Three Patients from Suriname. Front Neurol (2016) 0.75
Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain-Barré Syndrome. Neurocrit Care (2017) 0.75
Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Genes Immun (2014) 0.75
Peripheral neuropathies: Biomarkers for axonal damage in immune-mediated neuropathy. Nat Rev Neurol (2009) 0.75
Acute Motor Axonal Neuropathy (Aman) With Motor Conduction Blocks In Childhood; Case Report. Iran J Child Neurol (2016) 0.75
Subtypes and Prognosis of Guillain-Barré Syndrome in Southwest China. PLoS One (2015) 0.75
Muscle MRI in severe Guillain-Barré syndrome with motor nerve inexcitability. J Neurol (2013) 0.75
Predictive factors for achieving independent walking in children with Guillain-Barre Syndrome. Pediatr Res (2017) 0.75
Posttraumatic Guillain-Barré Syndrome Immediately Following a Traffic Accident. Korean J Spine (2017) 0.75
Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome. Sci Rep (2017) 0.75
Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification. J Neurol (2016) 0.75
Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria. J Neurol (2016) 0.75
Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome. J Neurol (2016) 0.75
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol (1990) 8.54
Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2011) 7.09
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04
A long-term controlled trial of screening for hypertension in general practice. Lancet (1976) 6.72
Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med (1995) 5.73
Social factors and height of primary schoolchildren in England and Scotland. J Epidemiol Community Health (1978) 4.73
Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A (1997) 4.70
Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales. BMJ (1993) 4.55
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology (2006) 4.38
Controlled trial prednisolone in acute polyneuropathy. Lancet (1978) 3.71
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol (1999) 3.67
The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology (2003) 3.60
Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest (1994) 3.58
Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol (1998) 3.39
Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.23
Botulinum toxin for palmar hyperhidrosis. Lancet (1997) 3.17
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology (1996) 2.94
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92
Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet (1991) 2.87
New cases seen at genitourinary medicine clinics: England 1997. Commun Dis Rep CDR Suppl (1998) 2.83
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2003) 2.76
Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation (1990) 2.74
The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect (2001) 2.69
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol (1990) 2.66
A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry (1988) 2.63
The development of smoking during adolescence--the MRC/Derbyshire Smoking Study. Int J Epidemiol (1983) 2.61
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry (1988) 2.56
Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry (1997) 2.52
Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology (Oxford) (2004) 2.37
Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology (2002) 2.34
Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology (2008) 2.29
Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain (1995) 2.29
Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol (1993) 2.23
Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med (1977) 2.23
Health effects of particulate pollution: reappraising the evidence. Am J Epidemiol (1979) 2.19
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology (1997) 2.15
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 2.12
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol (1988) 2.12
A role for BDNF in mechanosensation. Nat Neurosci (1998) 2.08
The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol (2000) 2.07
Epidemiological study of Guillain-Barré syndrome in south east England. J Neurol Neurosurg Psychiatry (1998) 2.07
The psychometric properties of clinical rating scales used in multiple sclerosis. Brain (1999) 2.06
Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol (1987) 2.05
Association between gas cooking and respiratory disease in children. Br Med J (1977) 2.03
The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler (1999) 2.02
Imaging in transient regional osteoporosis. Br J Rheumatol (1997) 2.01
Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med (1991) 2.01
Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clin Oncol (R Coll Radiol) (1991) 1.98
Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology (1995) 1.95
Demand for DNA probe testing in three genetic centres in Britain (August 1986 to July 1987). J Med Genet (1989) 1.95
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology (1999) 1.93
P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (2001) 1.92
Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol (1990) 1.92
The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol (1993) 1.92
Myasthenia gravis: passive transfer from man to mouse. Science (1975) 1.90
Ethnic variation in forced expiratory volume and forced vital capacity of African and Indian adults in Guyana. Am Rev Respir Dis (1970) 1.87
Relapsing polychondritis. Three cases with a clinico-pathological study and literature review. Q J Med (1972) 1.87
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS. Neurology (2002) 1.86
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis. Mult Scler (2002) 1.86
Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85
The St. Thomas's Hospital maternity case notes study: a randomised controlled trial to assess the effects of giving expectant mothers their own maternity case notes. Paediatr Perinat Epidemiol (1987) 1.83
Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol (1998) 1.83
Overview of azathioprine treatment in multiple sclerosis. Lancet (1991) 1.83
Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections. J Neurol Neurosurg Psychiatry (2005) 1.82
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology (1999) 1.80
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology (2010) 1.80
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler (2002) 1.80
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res (2000) 1.80
Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2000) 1.77
Relapse in Guillain-Barré syndrome after treatment with human immune globulin. Neurology (1993) 1.77
Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler (2001) 1.76
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics (1997) 1.70
Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med (2001) 1.69
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med (2001) 1.69
Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci U S A (1996) 1.68
Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med (1993) 1.67
Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother (1991) 1.67
Dominant GDAP1 mutations cause predominantly mild CMT phenotypes. Neurology (2011) 1.67
Late degenerative changes after meniscectomy. Factors affecting the knee after operation. J Bone Joint Surg Br (1984) 1.66